As of April 30, 2026, a research team at McGill University in Montreal has made a pivotal advancement in the field of emergency medicine with the development of "click clotting." This innovative technique enables the rapid formation of robust blood clots, offering a life-saving solution for severe hemorrhaging and enhancing treatment options for patients with clotting disorders.

Dr. Jianyu Li, a mechanical engineering professor and senior author of the study, explains that the ability to manage significant blood loss—also known as hemorrhage—is crucial, especially since traditional methods have inherent limitations. The click clotting process leverages a person's own blood or donor blood to create more effective clots through a chemical reaction, yielding clots that are 13 times tougher and four times more adhesive than natural blood clots. Key Advantages of Click Clotting

Rapid formation: Clots created using this method can form within 10 to 20 minutes, significantly faster than existing techniques that can take up to five minutes. Immediate response: In ideal conditions, artificial blood clots can stop bleeding in just seconds, acting almost instantaneously upon application. Greater resilience: The enhanced clots exhibit a durability that promotes better healing, making them suitable for emergency care and surgical situations.

The technique was first led by Shuaibing Jiang, a postdoctoral associate now affiliated with Harvard Medical School, during his PhD studies at McGill. Collaborative efforts involved researchers from multiple institutions, including the University of British Columbia and the Medical College of Wisconsin.

Previous attempts to use blood cells for similar applications faced challenges, such as brittleness and inconsistent clotting. Click clotting, however, resolves these issues by using a bio-safe chemical reaction to create a stable structure without interfering with natural blood chemistry. The resultant artificial cell-based gel, termed a cytogel, embeds itself within the body's existing fibrin clots, enhancing their functionality. Research Findings and Future Steps

The efficacy of click clotting has been validated through in vitro tests and on rodent models, indicating promising healing outcomes, particularly in damaged tissues such as the liver. Notably, the studies showed minimal immune reaction and no toxicity in major organs, underscoring the safety of this new approach.

However, Dr. Li cautions that before it can be fully integrated into clinical practice, further extensive research, including trials in larger animal models and eventually in humans, is essential. The goal is to identify optimal settings for application, whether in trauma care or routine surgeries.

This groundbreaking technology exemplifies how tailored engineering solutions in the medical field can drastically enhance patient outcomes, paving the way for improved emergency interventions and care strategies.